In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of <i>M. tuberculosis</i> H37Rv: Rifampicin Derivatives Target VapC2 of <i>Mtb</i> H37Rv
The emergence of multi-drug-resistant <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) strains has rendered many of the currently available anti-TB drugs ineffective. Hence, there is a pressing need to discover new potential drug targets/candidates. In this study, attempts have...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/4/1652 |